Biogen receives FDA approval for breakthrough ALS treatment:

Cambridge, Massachusetts-based Biogen has gotten the green light for a breakthrough ALS treatment that targets a devastating, ultra-rare genetic form of the progressive neurodegenerative disease. The U.S. Food and Drug

Related Keywords

Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , Jean Swidler , Christopher Viehbacher , Amylyx Pharmaceuticals , Drug Administration On , Massachusetts Based Biogen , Drug Administration , Ice Bucket Challenge , Bucket Challenge , Science And Technology , Scientific Research , Usiness And Commerce , Product Research And Development , New Products , Da Final Approval , Ealth And Wellness , Medical And Pharmaceutical Regulation , Drug And Device Approval Process , Drug Testing And Approval Process , Egulatory Drug Approval , Reatments And Therapies , Edicinal Drugs , Rading Impact Ice Codes Important Corporate Events , Rug And Device Regulatory Impact , Business Operations , Olitics And Government , Overnment Agencies Us , Department Of Health And Human Services , Food And Drug Administration , Government Regulation , Tructured Content , Positive Events , North America , Americas , Medicine , Ytology , Rade , Natomy , Enetics , Hysiology , Business , Harmacology ,